Echo IQ is trading 5.15% up now at A$0.51, with the September 15, 2026 rebound appearing supported by broader software-sector strength.

  • Software stocks gained 3.10%.
  • The rebound follows several sessions of heavy selling triggered by the FDA’s Not Substantially Equivalent determination for EchoSolv HF on September 9, 2026.
  • No new company-specific announcement was identified; Echo IQ’s FDA review and potential regulatory pathways remain key context.